Annual Accounts Payable
$1000.00
-$1000.00-50.00%
31 December 2023
Summary:
XTL Biopharmaceuticals annual accounts payable is currently $1000.00, with the most recent change of -$1000.00 (-50.00%) on 31 December 2023. During the last 3 years, it has fallen by -$1000.00 (-50.00%). XTLB annual accounts payable is now -99.97% below its all-time high of $3.13 million, reached on 31 December 2004.XTLB Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$223.00 K
+$222.00 K+22200.00%
31 March 2024
Summary:
XTL Biopharmaceuticals quarterly accounts payable is currently $223.00 thousand, with the most recent change of +$222.00 thousand (+22200.00%) on 31 March 2024. Over the past year, it has increased by +$61.00 thousand (+37.65%). XTLB quarterly accounts payable is now -94.74% below its all-time high of $4.24 million, reached on 30 June 2008.XTLB Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
XTLB Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -50.0% | +37.6% |
| 3 y3 years | -50.0% | - |
| 5 y5 years | -99.6% | - |
XTLB Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -50.0% | at low | -7.5% | >+9999.0% |
| 5 y | 5 years | -99.6% | at low | -13.6% | >+9999.0% |
| alltime | all time | -100.0% | at low | -94.7% | >+9999.0% |
XTL Biopharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2024 | - | $223.00 K(>+9900.0%) |
| Dec 2023 | $1000.00(-50.0%) | $1000.00(-99.4%) |
| Sept 2023 | - | $162.00 K(-0.6%) |
| June 2023 | - | $163.00 K(-32.4%) |
| Mar 2023 | - | $241.00 K(>+9900.0%) |
| Dec 2022 | $2000.00(0.0%) | $2000.00(0.0%) |
| Dec 2021 | $2000.00(0.0%) | $2000.00(-99.2%) |
| June 2021 | - | $258.00 K(>+9900.0%) |
| Dec 2020 | $2000.00(+100.0%) | $2000.00(+100.0%) |
| Dec 2019 | $1000.00(-99.6%) | $1000.00(-99.6%) |
| Dec 2018 | $253.00 K(+6225.0%) | $253.00 K(+6225.0%) |
| Dec 2017 | $4000.00(-73.3%) | $4000.00(-73.3%) |
| Dec 2016 | $15.00 K(-82.1%) | $15.00 K(-77.9%) |
| June 2016 | - | $68.00 K(-19.0%) |
| Dec 2015 | $84.00 K(-39.6%) | $84.00 K(+61.5%) |
| Sept 2015 | - | $52.00 K(-14.8%) |
| June 2015 | - | $61.00 K(-56.1%) |
| Dec 2014 | $139.00 K(-69.5%) | $139.00 K(-71.3%) |
| Sept 2014 | - | $484.00 K(-7.8%) |
| June 2014 | - | $525.00 K(+38.5%) |
| Mar 2014 | - | $379.00 K(-16.7%) |
| Dec 2013 | $455.00 K | $455.00 K(-31.3%) |
| Sept 2013 | - | $662.00 K(0.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2013 | - | $662.00 K(-17.6%) |
| Mar 2013 | - | $803.00 K(+34.7%) |
| Dec 2012 | $596.00 K(-72.2%) | $596.00 K(-10.4%) |
| Sept 2012 | - | $665.00 K(+1.5%) |
| June 2012 | - | $655.00 K(-1.4%) |
| Mar 2012 | - | $664.00 K(+3.3%) |
| Sept 2011 | - | $643.00 K(-7.9%) |
| June 2011 | - | $698.00 K(-15.4%) |
| Mar 2011 | - | $825.00 K(-7.0%) |
| Sept 2010 | - | $887.00 K(+0.6%) |
| June 2010 | - | $882.00 K(+20.3%) |
| Mar 2010 | - | $733.00 K(+15.8%) |
| Sept 2009 | - | $633.00 K(-85.1%) |
| June 2008 | - | $4.24 M(+97.6%) |
| Dec 2007 | $2.14 M(+127.8%) | $2.14 M(-31.5%) |
| June 2007 | - | $3.13 M(+232.6%) |
| Dec 2006 | $941.00 K(-53.1%) | $941.00 K(-65.2%) |
| June 2006 | - | $2.71 M(+34.8%) |
| Dec 2005 | $2.01 M(-36.0%) | $2.01 M(+96.8%) |
| June 2005 | - | $1.02 M(-67.5%) |
| Dec 2004 | $3.13 M(+4.4%) | $3.13 M(+63.8%) |
| June 2004 | - | $1.91 M |
| Dec 2003 | $3.00 M | - |
FAQ
- What is XTL Biopharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals annual accounts payable year-on-year change?
- What is XTL Biopharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for XTL Biopharmaceuticals?
- What is XTL Biopharmaceuticals quarterly accounts payable year-on-year change?
What is XTL Biopharmaceuticals annual accounts payable?
The current annual accounts payable of XTLB is $1000.00
What is the all time high annual accounts payable for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high annual accounts payable is $3.13 M
What is XTL Biopharmaceuticals annual accounts payable year-on-year change?
Over the past year, XTLB annual accounts payable has changed by -$1000.00 (-50.00%)
What is XTL Biopharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of XTLB is $223.00 K
What is the all time high quarterly accounts payable for XTL Biopharmaceuticals?
XTL Biopharmaceuticals all-time high quarterly accounts payable is $4.24 M
What is XTL Biopharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, XTLB quarterly accounts payable has changed by +$61.00 K (+37.65%)